Inclusion Criteria:~* Diagnosis of Alzheimer's Disease.~* MMSE 12-26 inclusive.~* If on existing anti-dementia
therapy, have been on a stable dose of anti-dementia therapy (cholinesterase inhibitors and/or memantine) for
at least 60 days prior to dosing in study.~* If not taking existing anti-dementia therapy, have not received
therapy with cholinesterase inhibitors and/or memantine within 60 days prior to dosing in this study.~
